Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial
- 1 December 1996
- journal article
- clinical trial
- Published by Springer Nature in The Italian Journal of Neurological Sciences
- Vol. 17 (6) , 429-432
- https://doi.org/10.1007/bf01997718
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial EpilepsyEpilepsia, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial SeizuresEpilepsia, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosagesNeurology, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology, 1996
- VigabatrinEpilepsia, 1995
- Topiramate: Preclinical Evaluation of a Structurally Novel AnticonvulsantEpilepsia, 1994
- Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-.beta.-D-fructopyranose sulfamate and related compoundsJournal of Medicinal Chemistry, 1987